Clinical Trials

If your child has received a cancer diagnosis, you want to make sure your child has the best that modern medicine has to offer. Mary Bridge Children’s oncology program gives children the chance to participate in clinical trials testing the most promising new cancer drugs and treatments.

The Children’s Oncology Group

The Children’s Oncology Group is a nonprofit group partnering with researchers worldwide to find the most effective cancer treatments.

Through our affiliation with the Children’s Oncology Group, we are able to offer patients the opportunity to participate in a wide variety of clinical trials. This affiliation also means our specialists utilize the same standardized care procedures used in large research institutions nationwide.

Clinical Trials at Mary Bridge

Most clinical trials focus on chemotherapy drugs used to treat cancer. At Mary Bridge, clinical trials are coordinated through MultiCare Institute of Research and Innovation (MIRI), our health care system’s research division.

Mary Bridge offers pediatric patients access to phase II clinical trials. Phase II clinical trials center on drugs already evaluated for safety during phase I clinical trials. Clinical trial opportunities change frequently, with past studies at Mary Bridge focusing on issues such as:

  • Identifying new chemotherapy drugs to treat pediatric cancers
  • Understanding the needs of adolescent and young adult cancer patients
  • Studying the relationship between adolescent cancer, depression and spirituality

How Do Clinical Trials Work?

If your child receives a cancer diagnosis, our specialists will discuss your child’s options for participating in a clinical trial. Enrolling is as simple as filling out the paperwork, if your child is eligible to participate. Your child’s pediatric cancer specialist will administer the treatment.

During the clinical trial, your child will receive innovative treatment not yet available to the wider public. Specialists will follow your child closely during and after treatment to monitor for side effects. Learn more about clinical trials offered through the MultiCare Institute of Research and Innovation (MIRI), our health system’s research program.

Contact Us

To make an appointment, please call 253-403-3481.